Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Reaction Biology Corp. provides integrated kinase discovery and target profiling services for drug development, offering biochemical, cellular, biophysical, and in vivo assays across kinases, epigenetic enzymes, GPCRs, PARP, and related pathways. The company also supplies custom assay development, protein production, and assay kits, with oncology- and immuno-oncology-focused platforms, including 3D tumor models, in vivo pharmacology models, and a CAR-T cell therapy platform. It offers research tools and resources such as Kinase Mapper, MoA Finder, LinkLight protein-protein interaction assays, and a catalog of recombinant proteins, substrates, and modulators to support kinase and epigenetic drug discovery.
The market map
Biopharma Research Platforms and Services →Where AI ranks Reaction Biology